New patent for Intra-cellular drug CAPLYTA – DrugPatentWatch

siteadmin January 7, 2022
Copyright © DrugPatentWatch. Originally published at New patent for Intra-cellular drug CAPLYTA


Annual Drug Patent Expirations for CAPLYTA

Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug.

CAPLYTA drug price trends.

Drug patent…

Source: www.drugpatentwatch.com and Read More